EX-10.2 3 w11856exv10w2.htm SCIENTIFIC ADVISORY BOARD CONSULTING AGREEMENTScience Advisory Board Consulting Agreement • May 5th, 2020 • New Jersey
Exhibit 10.2 BARRIER THERAPEUTICS, INC. SCIENCE ADVISORY BOARD CONSULTING AGREEMENT This SCIENCE ADVISORY BOARD CONSULTING AGREEMENT (this “Agreement”) dated as of August 1, 2005 (the “Effective Date”), is entered into by and between Barrier Therapeutics, Inc., a Delaware corporation, having a principal place of business at 600 College Road East, Suite 3200, Princeton, New Jersey, 08540 (the “Company”), and Carl Ehmann, an individual with a principal address at 134 Broad Street, Charleston, South Carolina 29401 (the “Advisor”). WHEREAS, the Company continues to utilize a group of individuals as an advisory board for the purpose of reviewing the Company’s research, development and commercial plans and activities relating to research, manufacture, use and/or sale of pharmaceutical products (the “Advisory Board”); and WHEREAS, the Advisor has served as a member of the Company’s Advisory Board pursuant to that certain Science Advisory Board Consulting Agreement dated as of April 26, 2002 (
